- GlobeNewswire•4 days ago
SAN DIEGO, April 24, 2017-- Organovo Holdings, Inc., a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3 D bioprinting technology, announced the grant ...
- Motley Fool•10 days ago
How soon can the new CEO carry the human-tissue printer over the profitability threshold?
- TheStreet.com•17 days ago
The company's shares were up 24% ahead of market's open on an FDA approval.
ONVO : Summary for Organovo Holdings, Inc. - Yahoo Finance
Organovo Holdings, Inc. (ONVO)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||2.50 x 2000|
|Ask||3.12 x 300|
|Day's Range||2.85 - 2.91|
|52 Week Range||2.41 - 4.99|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.90|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|